Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUPP.L Regulatory News (SUPP)

  • There is currently no data for SUPP

BenevolentAI Transaction Completion

26 Apr 2022 15:37

RNS Number : 4175J
Schroder UK Public Private Tst plc
26 April 2022
 

Schroder UK Public Private Trust plc (the "Company")

BenevolentAI Transaction Completion

 

The Company (LSE: SUPP) is pleased to announce the completion of BenevolentAI's business combination with Odyssey Acquisition S.A. ("Odyssey"), a Euronext Amsterdam-listed investment company. For further information on the transaction, investors can refer to the announcement made by the Company on 6th December 2021.

Assuming sufficient secondary market liquidity, BenevolentAI will henceforth be valued using its unadjusted quoted price which will be reflected in the Company's daily indicative unaudited NAV per share as of 25th April 2022. The valuation impact of the transaction has already been partially reflected in the Company's net asset value with the AIFM increasing the valuation of the holding from £22.4 million as at 30 September 2021 to £28.5 million as at 31 December 2021. It is anticipated that the value of the Company's holding as of 25th April 2022 will be approximately £39.6 million (€47.1 million) reflecting a further fair value increase of £11.1 million since 31 December 2021.

 

Enquiries:

Schroder Investment Management Limited

Estelle Bibby (Press) 0207 658 3431

John Spedding 0207 658 3206

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZQLFLLZLXBBZ
Date   Source Headline
9th Dec 202210:34 amRNSNet Asset Value(s)
8th Dec 202210:54 amRNSNet Asset Value(s)
7th Dec 20224:47 pmRNSTransaction in Own Shares
7th Dec 202210:51 amRNSNet Asset Value(s)
6th Dec 202210:47 amRNSNet Asset Value(s)
5th Dec 202210:40 amRNSNet Asset Value(s)
2nd Dec 202210:46 amRNSNet Asset Value(s)
1st Dec 202211:51 amRNSNet Asset Value(s)
30th Nov 20225:24 pmRNSTotal Voting Rights
30th Nov 202210:39 amRNSNet Asset Value(s)
29th Nov 20225:10 pmRNSTransaction in Own Shares
29th Nov 202210:52 amRNSNet Asset Value(s)
28th Nov 202210:56 amRNSNet Asset Value(s)
25th Nov 202210:58 amRNSNet Asset Value(s)
24th Nov 202211:49 amRNSNet Asset Value(s)
23rd Nov 20224:56 pmRNSTransaction in Own Shares
23rd Nov 202210:39 amRNSNet Asset Value(s)
22nd Nov 202211:30 amRNSNet Asset Value(s)
21st Nov 202211:17 amRNSNet Asset Value(s)
18th Nov 202211:24 amRNSNet Asset Value(s)
17th Nov 20224:55 pmRNSTransaction in Own Shares
17th Nov 202211:13 amRNSNet Asset Value(s)
17th Nov 20227:00 amRNSInvestment in A2 Biotherapeutics
16th Nov 202211:01 amRNSNet Asset Value(s)
15th Nov 202211:23 amRNSNet Asset Value(s)
14th Nov 202211:32 amRNSNet Asset Value(s)
11th Nov 202211:32 amRNSNet Asset Value(s)
10th Nov 202211:35 amRNSNet Asset Value(s)
9th Nov 20224:40 pmRNSSecond Price Monitoring Extn
9th Nov 20224:35 pmRNSPrice Monitoring Extension
9th Nov 202211:46 amRNSNet Asset Value(s)
8th Nov 202211:41 amRNSNet Asset Value(s)
7th Nov 20224:54 pmRNSTransaction in Own Shares
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
7th Nov 20224:35 pmRNSPrice Monitoring Extension
7th Nov 202211:51 amRNSNet Asset Value(s)
4th Nov 20225:58 pmRNSTransaction in Own Shares
4th Nov 20224:41 pmRNSSecond Price Monitoring Extn
4th Nov 20224:35 pmRNSPrice Monitoring Extension
4th Nov 202211:53 amRNSNet Asset Value(s)
4th Nov 20227:00 amRNSInvestment in iOnctura
3rd Nov 20225:09 pmRNSTransaction in Own Shares
3rd Nov 202211:23 amRNSNet Asset Value(s)
2nd Nov 20225:43 pmRNSTransaction in Own Shares
2nd Nov 202211:06 amRNSNet Asset Value(s)
2nd Nov 20227:00 amRNSKepler Trust Intelligence: New Research
1st Nov 202211:16 amRNSNet Asset Value(s)
31st Oct 20225:30 pmRNSTotal Voting Rights
31st Oct 20225:17 pmRNSTransaction in Own Shares
31st Oct 202211:31 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.